Boswellia for Osteoarthritis

Evidence grade B — Reasonable RCT support

Assembled by the app from other entries in this library. It adds no evidence of its own — follow the links to the entries it draws on.

1 at grade B — 1 graded row

What is known

Each outcome with its grade (how strong the evidence is, A to D), the size of the effect where the entry records one, and how often studies agree.

Outcome	Grade	Effect size	Agreement
OsteoarthritisReasonable RCT support	Evidence grade B	Unclear	mixed

Read off the same rows as above. Nothing here is added that the entry does not itself record.

For osteoarthritis, Boswellia earns evidence grade B (unclear effect, mixed consistency) — there is real evidence here. Reasonable RCT support

Boswellic acids inhibit 5-lipoxygenase and leukotriene synthesis, a distinct anti-inflammatory pathway from NSAIDs.

100–250 mg/day of a high-AKBA standardized extract (product-dependent).

Well tolerated; occasional GI upset.

One of the more convincing joint botanicals for osteoarthritis pain. Use a standardized high-AKBA extract and give it a couple of weeks.

As the entry records it, from the studies it summarises. Not a recommendation for you — doses that suit a trial population may not suit you.

Entries that share this one's tags or conditions.

Boswellia for Osteoarthritis pain/functionEvidence grade B — Standardized extractsEvidence grade B
Curcumin (Turmeric) for OsteoarthritisEvidence grade B — Bioavailable formsEvidence grade B
Glucosamine for OsteoarthritisEvidence grade C — Trial for 8–12 weeksEvidence grade C
Boswellia: dosage and how to take it100–250 mg/day high-AKBA extract.Evidence grade B

This entry lists no references of its own — it is assembled from the entries it links to, whose sources are on their pages.

Last revised Jul 10, 2026. A grade is this entry's reading of the evidence, not medical advice.